2‐hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species M Sakko, C Moore, L Novak‐Frazer, V Rautemaa, T Sorsa, P Hietala, ... Mycoses 57 (4), 214-221, 2014 | 61 | 2014 |
Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital R Rautemaa-Richardson, V Rautemaa, F Al-Wathiqi, CB Moore, L Craig, ... Journal of Antimicrobial Chemotherapy 73 (12), 3488-3495, 2018 | 52 | 2018 |
A Novel Antifungal Is Active against Candida albicans Biofilms and Inhibits Mutagenic Acetaldehyde Production In Vitro MT Nieminen, L Novak-Frazer, V Rautemaa, R Rajendran, T Sorsa, ... Plos one 9 (5), e97864, 2014 | 49 | 2014 |
High level of β-(1, 3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease V Rautemaa, HD Green, AM Jones, R Rautemaa-Richardson Diagnostic Microbiology and Infectious Disease 88 (4), 316-321, 2017 | 11 | 2017 |
Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy? O Ragy, V Rautemaa, A Smith, P Brenchley, D Kanigicherla, P Hamilton PLoS One 18 (2), e0281726, 2023 | 5 | 2023 |
The role of noninvasive ventilation in the management of type II respiratory failure in patients with myotonic dystrophy V Rautemaa, ME Roberts, A Bentley, TW Felton ERJ Open Research 7 (3), 2021 | 4 | 2021 |
Can the Use of the Serum Anti-PLA2R Antibody Negate the Need for a Renal Biopsy in Primary Membranous Nephropathy?: PO1475 OS Ragy, V Rautemaa, DAK Kanigicherla, P Hamilton Journal of the American Society of Nephrology 32 (10S), 465, 2021 | | 2021 |
P198 Non-invasive ventilation in the management of type II respiratory failure in myotonic dystrophy V Rautemaa, M Roberts, AM Bentley, TW Felton Thorax 73 (Suppl 4), A208-A208, 2018 | | 2018 |
WS20. 2 High level of β-(1, 3)-D-glucan antigenemia in cystic fibrosis in the absence of systemic fungal infection V Rautemaa, H Green, R Richardson, AM Jones Journal of Cystic Fibrosis 1 (15), S31, 2016 | | 2016 |